Patients scheduled for colonoscopy colonoscopy
Conditions
Interventions
Perform colonoscopy after taking Picoprep by the single oral dose
taking Picoprep by the the single oral dose
Sponsors
Kodama Yuzo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. patients undergoing colonoscopy 2. age 18 years or older at the time of informed consent 3. pssible to take laxatives 4. possible to give written consent on his/her own
Exclusion criteria
Exclusion criteria: 1. patients with severe renal dysfunction (eGFR< 30 mL/ min/ 1.73m2) 2. patients with severe heart failure (NYHA class III or IV) 3. patients with hyponaemia (<136 mEq/L) or hypokalaemia (<3.5 mEq/L) 4. Patients with previous surgical resection of the colon or rectum (except for appendectomy and small bowel resection) 5. patients with suspected intestinal obstruction or perforation 6. patients with suspected hemorrhagic lesions such as hemorrhage 7. Patients with suspected or pre-existing inflammatory bowel disease 8. pregnant women and patients who may be pregnant or lactating women 9. patients who have participated in another interventional study within 4 months 10. other patients deemed inappropriate by the investigators of this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adequate bowel preparation rate (BBPS >= 6 points and >= 2 points in all segments) | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficucy endopoints Boston bowel preparation score (BBPS) in the single oral dose method Patient satisfaction score, Intubation time (time from anal insertion to cecum), Cecum intubation Adenoma detection rate Safety endopoint Occurence of side efect | — |
Contacts
Public ContactHitomi Hori
Kobe University Hospital
Outcome results
None listed